BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16261308)

  • 1. Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects.
    Walker M; Mari A; Jayapaul MK; Bennett SM; Ferrannini E
    Diabetologia; 2005 Dec; 48(12):2470-6. PubMed ID: 16261308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
    Henninger J; Hammarstedt A; Rawshani A; Eliasson B
    BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset.
    Ferrannini E; Mari A; Nofrate V; Sosenko JM; Skyler JS;
    Diabetes; 2010 Mar; 59(3):679-85. PubMed ID: 20028949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of non-diabetic hyperglycemia: a longitudinal study.
    Oka R; Yagi K; Hayashi K; Kawashiri MA; Yamagishi M; Yamada M; Fumisawa Y; Yamauchi K; Aizawa T
    Endocr J; 2014; 61(1):91-9. PubMed ID: 24153000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes.
    Cnop M; Vidal J; Hull RL; Utzschneider KM; Carr DB; Schraw T; Scherer PE; Boyko EJ; Fujimoto WY; Kahn SE
    Diabetes Care; 2007 Mar; 30(3):677-82. PubMed ID: 17327340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic and metabolic characteristics of individuals with progressive glucose tolerance.
    Mendes AL; Santos ML; Padovani CR; Pimenta WP
    Braz J Med Biol Res; 2009 Mar; 42(3):279-88. PubMed ID: 19287907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study.
    Kayaniyil S; Retnakaran R; Harris SB; Vieth R; Knight JA; Gerstein HC; Perkins BA; Zinman B; Hanley AJ
    Diabetes; 2011 Nov; 60(11):2947-53. PubMed ID: 21911752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining pancreatic β-cell compensation for changing insulin sensitivity using an oral glucose tolerance test.
    Solomon TP; Malin SK; Karstoft K; Knudsen SH; Haus JM; Laye MJ; Pedersen M; Pedersen BK; Kirwan JP
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E822-9. PubMed ID: 25184989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes.
    Thamer C; Haap M; Heller E; Joel L; Braun S; Tschritter O; Haring H; Fritsche A
    Horm Metab Res; 2006 Mar; 38(3):178-82. PubMed ID: 16673209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of impaired glucose tolerance: follow-up at Joslin Clinic.
    Warram JH; Sigal RJ; Martin BC; Krolewski AS; Soeldner JS
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S40-5. PubMed ID: 8894480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Each degree of glucose intolerance in pregnancy predicts distinct trajectories of β-cell function, insulin sensitivity, and glycemia in the first 3 years postpartum.
    Kramer CK; Swaminathan B; Hanley AJ; Connelly PW; Sermer M; Zinman B; Retnakaran R
    Diabetes Care; 2014 Dec; 37(12):3262-9. PubMed ID: 25231898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.
    Guerrero-Romero F; Rodríguez-Morán M
    Eur J Clin Invest; 2006 Nov; 36(11):796-802. PubMed ID: 17032347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Cell function in postmenopausal women with isolated post-challenge hyperglycemia.
    Hwu CM; Lin YC; Lin KH
    J Diabetes; 2018 Feb; 10(2):158-165. PubMed ID: 28544644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deteriorating beta cell function is the dominant determinant of progression from normal glucose tolerance to prediabetes/diabetes in young women following pregnancy.
    Retnakaran R; Ye C; Kramer CK; Hanley AJ; Connelly PW; Sermer M; Zinman B
    Diabetologia; 2023 Nov; 66(11):2154-2163. PubMed ID: 37612415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes.
    Tura A; Mari A; Prikoszovich T; Pacini G; Kautzky-Willer A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):237-43. PubMed ID: 18194489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
    Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
    Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function.
    Mari A; Manco M; Guidone C; Nanni G; Castagneto M; Mingrone G; Ferrannini E
    Diabetologia; 2006 Sep; 49(9):2136-43. PubMed ID: 16819611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.
    Utzschneider KM; Prigeon RL; Faulenbach MV; Tong J; Carr DB; Boyko EJ; Leonetti DL; McNeely MJ; Fujimoto WY; Kahn SE
    Diabetes Care; 2009 Feb; 32(2):335-41. PubMed ID: 18957530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.